Abbott Laboratories

XETRA:ABL

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ABL's stock price target?

Price Target

105.27 EUR

According to Wall Street analysts, the average 1-year price target for ABL is 105.27 EUR with a low forecast of 89.47 EUR and a high forecast of 122.81 EUR.

What is the Revenue forecast for Abbott Laboratories?

Projected CAGR

9%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.

What is the Gross Profit forecast for Abbott Laboratories?

Projected CAGR

9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 7 years is 9%.

What is the Operating Income forecast for Abbott Laboratories?

Projected CAGR

14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.

What is the Pre-Tax Income forecast for Abbott Laboratories?

Projected CAGR

18%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.

What is the Net Income forecast for Abbott Laboratories?

Projected CAGR

15%

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.